DOI: 10.1055/s-00000059

Pneumologie

References

Singh D, Papi A, Corradi M. et al.
Single inhaler triple therapy versus inhaled corticosteroid plus long-acting β2-agonist therapy for chronic obstructive pulmonary disease (TRILOGY): a double-blind, parallel group, randomised controlled trial.

Lancet 2016;
388: 963-973

Singh D, Papi A, Corradi M. et al.
Single inhaler triple therapy versus inhaled corticosteroid plus long-acting β2-agonist therapy for chronic obstructive pulmonary disease (TRILOGY): a double-blind, parallel group, randomised controlled trial.

Lancet 2016;
388: 963-973

Download Bibliographical Data

Search in:
Access: